Respirology

Article	Citations
Global burden of sleep‐disordered breathing and its implications	134
Radiotherapy treatment for lung cancer: Current status and future directions	130
Comparison of the immunogenicity of BNT162b2 and CoronaVac COVID‐19 vaccines in Hong Kong	110
Summarizing societal guidelines regarding bronchoscopy during the COVID‐19 pandemic	81
Chronic obstructive pulmonary disease exacerbation fundamentals: Diagnosis, treatment, prevention and disease impact	63
COVID‐19 infection and the broader impacts of the pandemic on healthcare workers	59
Video‐assisted thoracoscopic surgery as the gold standard for lung cancer surgery	58
One‐year follow‐up CT findings in COVID‐19 patients: A systematic review and meta‐analysis	58
ACE2 expression is elevated in airway epithelial cells from older and male healthy individuals but reduced in asthma	56
Health impacts of bushfire smoke exposure in Australia	53
Airway stenting: Technological advancements and its role in interventional pulmonology	48
Rationale for universal face masks in public against COVID‐19	43
Natural history and mechanisms of COPD	43
Diagnosis and management of connective tissue disease‐associated interstitial lung disease in Australia and New Zealand: A position statement from the Thoracic Society of Australia and New Zealand*	42
Pulmonary alveolar proteinosis	42
Air pollution and the pandemic: Long‐term PM2.5 exposure and disease severity in COVID‐19 patients	38
Current global perspectives on silicosis—Convergence of old and newly emergent hazards	37
Pulmonary toxicity of systemic lung cancer therapy	37
Pathophysiology of infection with SARS‐CoV‐2—What is known and what remains a mystery	34
Clusters of sleep apnoea phenotypes: A large pan‐European study from the European Sleep Apnoea Database (ESADA)	33
Occupational COPD—The most under‐recognized occupational lung disease?	32
Exercise training as part of lung cancer therapy	32
Oral corticosteroids stewardship for asthma in adults and adolescents: A position paper from the Thoracic Society of Australia and New Zealand	32
Cost of hospitalization for bronchiectasis exacerbation in children	31
Effect of comorbid pulmonary disease on the severity of COVID‐19: A systematic review and meta‐analysis	30

Delay or avoidance of routine, urgent and emergency medical care due to concerns about COVID‐19 in a region with low COVID‐19 prevalence: Victoria, Australia	30
Treatable traits in the NOVELTY study	28
Stearic acid attenuates profibrotic signalling in idiopathic pulmonary fibrosis	28
Is tissue still the issue in detecting molecular alterations in lung cancer?	28
Serum markers of pulmonary epithelial damage in systemic sclerosis‐associated interstitial lung disease and disease progression	28
Lung cancer screening implementation: Complexities and priorities	28
Characteristics of bronchiectasis in Korea: First data from the Korean Multicentre Bronchiectasis Audit and Research Collaboration registry and comparison with other international registries	27
Coagulation markers as predictors for clinical events in COPD	27
Global Initiative for Asthma Strategy 2021	26
What have we learnt about asthma control from trials of budesonide/formoterol as maintenance and reliever?	26
Muscle loss contributes to higher morbidity and mortality in COPD: An analysis of national trends	26
Chest CT‐assessed comorbidities and all‐cause mortality risk in COPD patients in the BODE cohort	25
Abstracts	25
Acute effects of e‐cigarette vaping on pulmonary function and airway inflammation in healthy individuals and in patients with asthma	25
Epidemiology, clinical spectrum, viral kinetics and impact of COVID‐19 in the Asia‐Pacific region	25
Prednisolone and tacrolimus versus prednisolone and cyclosporin A to treat polymyositis/dermatomyositis‐associated ILD: A randomized, open‐label trial	24
Anti‐fibrotic effects of different sources of MSC in bleomycin‐induced lung fibrosis in C57BL6 male mice	24
Cause of mortality and sarcopenia in patients with idiopathic pulmonary fibrosis receiving antifibrotic therapy	24
Prevalence and burden of breathlessness in Australian adults: The National Breathlessness Survey—a cross‐sectional web‐based population survey	24
Pleuroparenchymal fibroelastosis in patients with idiopathic pulmonary fibrosis	24
Addition of zolpidem to combination therapy with atomoxetine‐oxybutynin increases sleep efficiency and the respiratory arousal threshold in obstructive sleep apnoea: A randomized trial	24
Risk prediction model in rheumatoid arthritis‐associated interstitial lung disease	24
Outcomes of protracted bacterial bronchitis in children: A 5‐year prospective cohort study	24
Bronchoscopy in COVID‐19 intensive care unit patients	24
Predictors of lung function trajectories in population‐based studies: A systematic review	23
Predictive value of control of COPD for risk of exacerbations: An international, prospective study	23
The role of SARS‐CoV‐2 antibodies in COVID‐19: Healing in most, harm at times	23
Risk of cancer incidence in patients with idiopathic pulmonary fibrosis: A nationwide cohort study	22
Supplemental oxygen improves exercise capacity in IPF patients with exertional desaturation	22
Pulmonary rehabilitation in COVID‐19 pandemic era: The need for a revised approach	22
Respiratory surveillance for coal mine dust and artificial stone exposed workers in Australia and New Zealand: A position statement from the Thoracic Society of Australia and New Zealand*	21
Tocilizumab administration for the treatment of hospitalized patients with COVID‐19: A systematic review and meta‐analysis	21
Time‐resolved proteomic profiling of cigarette smoke‐induced experimental chronic obstructive pulmonary disease	20
Ventilatory support at home for children: A joint position paper from the Thoracic Society of Australia and New Zealand/Australasian Sleep Association	20
Impact of early life exposures on COPD in adulthood: A systematic review and meta‐analysis	20
Safe performance of diagnostic bronchoscopy/EBUS during the SARS‐CoV‐2 pandemic	20
COVID‐19: Histopathological correlates of imaging patterns on chest computed tomography	19
Mental health among healthcare workers during the COVID‐19 pandemic	19
Characteristics and long‐term survival of patients with chronic thromboembolic pulmonary hypertension in China	19
Lung cancer in patients with idiopathic pulmonary fibrosis: A retrospective multicentre study in Europe	19
Face masks for community use: An awareness call to the differences in materials	19
Pharmacological treatment of stable chronic obstructive pulmonary disease	19
EBUS versus EUS‐B for diagnosing sarcoidosis: The International Sarcoidosis Assessment (ISA) randomized clinical trial	19
Predictors of CPAP outcome in hospitalized COVID‐19 patients	19
A comprehensible machine learning tool to differentially diagnose idiopathic pulmonary fibrosis from other chronic interstitial lung diseases	18
Mapping IPF helps identify geographic regions at higher risk for disease development and potential triggers	18
Effect of short‐course exercise training on the frequency of exacerbations and physical activity in patients with COPD: A randomized controlled trial	18
Targeting the interleukin‐17 pathway to prevent acute respiratory distress syndrome associated with SARS‐CoV‐2 infection	18
Contemporary perspectives in COPD: Patient burden, the role of gender and trajectories of multimorbidity	18
Clinical side effects of continuous positive airway pressure in patients with obstructive sleep apnoea	18

Prevalence and prognosis of chronic fibrosing interstitial lung diseases with a progressive phenotype	18
Electronic cigarettes: A position statement from the Thoracic Society of Australia and New Zealand*	18
Effects of chemical composition on the lung cell response to coal particles: Implications for coal workers' pneumoconiosis	17
National policies for paediatric universal BCG vaccination were associated with decreased mortality due to COVID‐19	16
Innovations in thoracic imaging: CT, radiomics, AI and x‐ray velocimetry	16
Sub‐stratification of type‐2 high airway disease for therapeutic decision‐making: A ‘bomb’ (blood eosinophils) meets ‘magnet’ (FeNO) framework	16
COVID‐19 situation in Pakistan: A broad overview	16
Efficacy and safety of virtual bronchoscopic navigation with fused fluoroscopy and vessel mapping for access of pulmonary lesions	16
Impact of COVID‐19 pandemic restrictions on the cardio‐respiratory health of New Zealanders	16
Surgical management of obstructive sleep apnoea: A position statement of the Australasian Sleep Association*	16
Bronchial thermoplasty versus mepolizumab: Comparison of outcomes in a severe asthma clinic	16
Delayed access to lung cancer screening and treatment during the COVID‐19 pandemic: Are we headed for a lung cancer pandemic?	16
Quantitative computed tomography predicts outcomes in idiopathic pulmonary fibrosis	15
Prevalence and prognostic impact of physical frailty in interstitial lung disease: A prospective cohort study	15
Infection risk in sarcoidosis patients treated with methotrexate compared to azathioprine: A retrospective ‘target trial’ emulated with Swedish real‐world data	15
Bronchoscopic treatments for early‐stage peripheral lung cancer: Are we ready for prime time?	15
Bronchoscopic interventions for severe emphysema: Where are we now?	15
Robotic‐assisted bronchoscopy versus CT‐guided transthoracic biopsy for diagnosis of pulmonary nodules	15
Disease burden of eosinophilic airway disease: Comparing severe asthma, COPD and asthma–COPD overlap	15
Characteristics, goal‐oriented treatments and survival of pulmonary arterial hypertension in China: Insights from a national multicentre prospective registry	15
Effect of high‐flow nasal cannula oxygen therapy on exercise tolerance in patients with idiopathic pulmonary fibrosis: A randomized crossover trial	14
Multiplanar 3D fluoroscopy redefines tool–lesion relationship during robotic‐assisted bronchoscopy	14
Central airway collapse is related to obesity independent of asthma phenotype	14
Defining successful non‐invasive ventilation initiation: Data from a real‐life cohort	14
Predictors of mortality in subjects with progressive fibrosing interstitial lung diseases	14
Risk factors for chronic cough in adults: A systematic review and meta‐analysis	14
Malignant pleural effusion survival prognostication in an Asian population	14
Serum amyloid A is a predictor for prognosis of COVID‐19	14
Respiratory management of infants with chronic neonatal lung disease beyond the NICU: A position statement from the Thoracic Society of Australia and New Zealand*	14
Universal public mask wear during COVID‐19 pandemic: Rationale, design and acceptability	14
Medical information and social media in the time of COVID‐19	14
Idiopathic pulmonary fibrosis: Physician and patient perspectives on the pathway to care from symptom recognition to diagnosis and disease burden	13
Peer Connect Service for people with pulmonary fibrosis in Australia: Participants' experiences and process evaluation	13
Atomoxetine and fesoterodine combination improves obstructive sleep apnoea severity in patients with milder upper airway collapsibility	13
Phosphodiesterase 5 inhibitor treatment and survival in interstitial lung disease pulmonary hypertension: A Bayesian retrospective observational cohort study	13
Letter from Indonesia	13
Thoracic Society of Australia and New Zealand (TSANZ) position statement on chronic suppurative lung disease and bronchiectasis in children, adolescents and adults in Austra	13
Global, regional and national burden of chronic obstructive pulmonary disease over a 30‐year period: Estimates from the 1990 to 2019 Global Burden of Disease Study	13
Anti‐IgE therapy inhibits chemotaxis, proliferation and transformation of circulating fibrocytes in patients with severe allergic asthma	13
Alteplase Dose Assessment for Pleural infection Therapy (ADAPT) Study‐2: Use of 2.5 mg alteplase as a starting intrapleural dose	12
Challenges faced in managing adult asthma: A perspective from Asian countries	12
Long‐term impact of coal mine fire smoke on lung mechanics in exposed adults	12
Chronic obstructive pulmonary disease (COPD) mortality trends worldwide: An update to 2019	12
Outcomes of patients with advanced idiopathic pulmonary fibrosis treated with nintedanib or pirfenidone in a real‐world multicentre cohort	12
Preoperative staging of the mediastinum is an essential and multidisciplinary task	12
Serum Krebs von den Lungen‐6 level in the disease progression and treatment of Mycobacterium avium complex lung disease	12
Pulmonary functional MRI: Detecting the structure–function pathologies that drive asthma symptoms and quality of life	12
Letter from Egypt	11
Aerosol‐generating procedures in the COVID era	11
Cryotherapy in the paediatric airway: Indications, success and safety	11
Effect of surgical intervention for mild childhood obstructive sleep apnoea on attention and behavioural outcomes: A randomized controlled study	11
Effectiveness of influenza and pneumococcal vaccines on chronic obstructive pulmonary disease exacerbations	11
Ultrathin bronchoscopic cryobiopsy of peripheral pulmonary lesions	11
Multi‐institutional retrospective analysis of adverse events following rigid tracheobronchoscopy	11
Inhalational exposures in patients with fibrotic interstitial lung disease: Presentation, pulmonary function and survival in the Canadian Registry for Pulmonary Fibrosis	11
Relation between sex hormones and leucocyte telomere length in men with idiopathic pulmonary fibrosis	11
Priorities and expectations of patients attending a multidisciplinary interstitial lung disease clinic	11
IL‐17A is a common and critical driver of impaired lung function and immunopathology induced by influenza virus, rhinovirus and respiratory syncytial virus	10
Contemporary narrative review of treatment options for COVID‐19	10
Reduced exercise tolerance in mild chronic obstructive pulmonary disease: The contribution of combined abnormalities of diffusing capacity for carbon monoxide and ventilatory efficiency	10
Trends of global and regional aetiologies, risk factors and mortality of lower respiratory infections from 1990 to 2019: An analysis for the Global Burden of Disease Study 2019	10
Chronic bronchial infection and incident cardiovascular events in chronic obstructive pulmonary disease patients: A long‐term observational study	10
Short‐term lung function changes predict mortality in patients with fibrotic hypersensitivity pneumonitis	10
Letter from Singapore: The clinical and research response to COVID‐19	10
An examination of two dichotomies: Women with lung cancer and living with lung cancer as a chronic disease	10
Endobronchial coils for emphysema: Dual mechanism of action on lobar residual volume reduction	10
Benefits of a virtual interstitial lung disease multidisciplinary meeting in the face of COVID‐19	10
Barriers and facilitators to best care for idiopathic pulmonary fibrosis in Australia	10
Incidence, prevalence and mortality of idiopathic pulmonary fibrosis in Australia	10
Malignant mesothelioma cells secrete natriuretic peptides: Data and diagnostic clinical implications	9
Pulmonary Daoyin as a traditional Chinese medicine rehabilitation programme for patients with IPF: A randomized controlled trial	9
Thoracic ultrasound as a predictor of pleurodesis success at the time of indwelling pleural catheter removal	9
Role of early definitive management for newly diagnosed malignant pleural effusion related to lung cancer	9
Secondary infection among hospitalized COVID‐19 patients: A retrospective cohort study in a tertiary care setting	9
Cardiovascular risks of children with primary snoring: A 5‐year follow‐up study	9
Impact of cold and flu medication on obstructive sleep apnoea and its underlying traits: A pilot randomized controlled trial	9
Genetic testing in interstitial lung disease: An international survey	9
Pleural effusions and pneumothorax: Beyond simple plumbing	9
Radiological outcomes of whole lung lavage for artificial stone‐associated silicosis	9
Effects of the combination of atomoxetine and oxybutynin in Japanese patients with obstructive sleep apnoea: A randomized controlled crossover trial	8

Partial anomalous pulmonary venous drainage in patients presenting with suspected pulmonary hypertension: A series of 90 patients from the ASPIRE registry	8
Home monitoring of lung function, symptoms and quality of life after admission with COVID‐19 infection: The HOMECOMIN' study	8
Direct and indirect costs of systemic sclerosis and associated interstitial lung disease: A nationwide population‐based cohort study	8
CPAP telemonitoring can track Cheyne–Stokes respiration and detect serious cardiac events: The AlertApnée Study	8
Foetal growth restriction and asthma: Airway smooth muscle thickness rather than just lung size?	8
Promotion of physical activity after hospitalization for COPD exacerbation: A randomized control trial	8
Cone‐beam computed tomography versus computed tomography‐guided ultrathin bronchoscopic diagnosis for peripheral pulmonary lesions: A propensity score‐matched analysis	8
The ‘great wait’ for diagnosis in pulmonary arterial hypertension	8
Cigarette smoke extract decreased basal and lipopolysaccharide‐induced expression of MARCO via degradation of p300	8
Examining the impact of multilevel upper airway surgery on the obstructive sleep apnoea endotypes and their utility in predicting surgical outcomes	8
Pulmonary fibrosis in non‐mutation carriers of families with short telomere syndrome gene mutations	8
Impact of recent catastrophic bushfires on people with asthma in Australia: Health, social and financial burdens	8
Thoracic Society of Australia and New Zealand Position Statement on Acute Oxygen Use in Adults: ‘Swimming between the flags’	8
The HUNT study: Association of comorbidity clusters with long‐term survival and incidence of exacerbation in a population‐based Norwegian COPD cohort	8
Periostin‐related progression of different types of experimental pulmonary hypertension: A role for M2 macrophage and FGF‐2 signalling	8
Respiratory admissions before and during the COVID‐19 pandemic with mediation analysis of air pollutants, mask‐wearing and influenza rates	7
Preoperative use of pirfenidone and reduced risk of postoperative severe respiratory complications in patients with idiopathic pulmonary fibrosis: Propensity score‐matched analysis using a nationwide	7
Animal models of COVID‐19 hyper‐inflammation	7
Sarcoidosis‐related mortality and the impact of corticosteroid treatment: A population‐based cohort study	7
High turnover of types III and VI collagen in progressive idiopathic pulmonary fibrosis	7
Reversal of collateral ventilation using endoscopic polymer foam in COPD patients undergoing endoscopic lung volume reduction with endobronchial valves: A controlled parallel group trial	7
Longitudinal changes in total and regional body composition in patients with chronic obstructive pulmonary disease	7
Medical ethics in the era of COVID‐19: Now and the future	7
Lung cryobiopsy and interstitial lung disease: What is its role in the era of multidisciplinary meetings and antifibrotics?	7
Comparing recalled versus experienced symptoms of breathlessness ratings: An ecological assessment study using mobile phone technology	7
Comparisons of early and late presentation to hospital in COVID‐19 patients	7
Why we still need drugs for COVID‐19 and can't just rely on vaccines	7
Laboratory performance of oronasal CPAP and adapted snorkel masks to entrain oxygen and CPAP	7
Bronchial thermoplasty: Redefining its role	7
Acute cigarette smoke‐induced eQTL affects formyl peptide receptor expression and lung function	6
The impact of regular bisoprolol on the response to salbutamol in asthma: A double‐blind randomized placebo‐controlled crossover trial	6
Extrapulmonary manifestations of a telomere syndrome in patients with idiopathic pulmonary fibrosis are associated with decreased survival	6
Features of humidifier lung and comparison with summer‐type hypersensitivity pneumonitis	6
COVID‐19 vaccine‐induced immunity: Head‐to‐head comparison of mRNA (BNT162b2) versus inactivated (CoronaVac) vaccines	6
Sleep‐disordered breathing was associated with lower health‐related quality of life and cognitive function in a cross‐sectional study of older adults	6
Physical activity decline is disproportionate to decline in pulmonary physiology in IPF	6
Fluticasone furoate: CAPTAIN of fluticasones in type 2 inflammatory asthma	6
Inhaled corticosteroid is not associated with a poor prognosis in COVID‐19	6
Thoracic manifestations of IgG4‐related disease	6
Geriatric Nutritional Risk Index is a predictor of tolerability of antifibrotic therapy and mortality risk in patients with idiopathic pulmonary fibrosis	6
Contemporary Concise Review 2021: Interstitial lung disease	6
Variations in lung cancer care and outcomes: How best to identify and improve standards of care?	6
Lung cancer staging: State of the art in the era of ablative therapies and surgical segmentectomy	6
Endobronchial coil spring fiducial markers for CyberKnife® stereotactic body radiation therapy	6
Contribution of obesity to breathlessness in a large nationally representative sample of Australian adults	6
Work‐related asthma: A position paper from the Thoracic Society of Australia and New Zealand and the National Asthma Council Australia	6
Role of endobronchial ultrasound strain elastography in the identification of fibrotic lymph nodes in sarcoidosis: A pilot study	6
Increased physical activity reduces sleep disturbances in asthma: A randomized controlled trial	6
Clinical utility of ventilatory and gas exchange evaluation during low‐intensity exercise for risk stratification and prognostication in pulmonary arterial hypertension	6
Disease progression across the spectrum of idiopathic pulmonary fibrosis: A multicentre study	6
Are e‐cigarette use and vaping associated with increased respiratory symptoms and poorer lung function in a population exposed to smoke from a coal mine fire?	5
Effect of obstructive sleep apnoea on coronary collateral vessel development in patients with ST‐segment elevation myocardial infarction	5
Biologics for severe asthma—Which, when and why?	5
3D printed airway simulators: Adding a dimension to bronchoscopy training	5
Concise guidance for COPD	5
Role of ventilatory control instability in children with sleep‐disordered breathing	5
Complications of rigid bronchoscopy	5
Anti‐inflammatory reliever therapy in asthma: The evidence mounts but more is needed	5
Predicting malignant pleural effusion during diagnostic pleuroscopy with biopsy: A prospective multicentre study	5
Contemporary Concise Review 2020: Asthma	5
Bronchial thermoplasty: State of the art	5
Risk of severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) transmission during bronchoscopy in the intensive care unit	5
Epidemiology of interstitial lung disease in systemic lupus erythematosus in France: A nation‐wide population‐based study over 10 years	5
Device assessed activity behaviours in patients with indwelling pleural catheter: A sub‐study of the Australasian Malignant PLeural Effusion (AMPLE)‐2 randomized trial	5
Pulmonary vascular involvement in COVID‐19 pneumonitis: Is this the first and final insult?	5
Tocilizumab therapy in individuals with COVID‐19 infection and hyperinflammatory state	5
Mapping air pollution and idiopathic pulmonary fibrosis	5
Letter from China: Managing the second‐wave COVID‐19 outbreak in Beijing	5
Nitrogen dioxide increases the risk of disease progression in idiopathic pulmonary fibrosis	5
Philip Morris International buys inhaler company Vectura to expand reach in electronic cigarettes	5
Opportunities to diagnose fibrotic lung diseases in routine care: A primary care cohort study	5
Interstitial lung diseases associated with mutations of poly(A)‐specific ribonuclease: A multicentre retrospective study	5
Supranormal lung function: Prevalence, associated factors and clinical manifestations across the lifespan	5
The needs and well‐being of severe asthma and COPD carers: A cross‐sectional study	5
Sleep and circadian health 6 months after critical COVID‐19 disease	5
The unmet care needs of progressive fibrosing interstitial lung disease	5
Growth of the airway smooth muscle layer from late gestation to childhood is mediated initially by hypertrophy and subsequently hyperplasia	5
Letter from China: Response after the first wave of COVID‐19	5
Antibiotic‐resistant bacteria: COVID‐19 hasn't made the challenge go away	5
Antifibrotics and lung transplantation: A Spanish multicentre case‐controlled study	5
Alveolar crystal burden in stone workers with artificial stone silicosis	5
TSANZ Abstracts	5
Robotic bronchoscopic needle‐based confocal laser endomicroscopy to diagnose peripheral lung nodules	5
Social distancing as a strategy to prevent respiratory virus infections	5
The 1918 influenza and COVID‐19 pandemics: The effect of age on outcomes	4
Identifying the asthma research priorities of people with asthma, their carers and other stakeholders	4
Severe COVID‐19 and interleukin‐6 receptor antagonist tocilizumab: Some notes of concern	4
Letter from Iran: Experiences with COVID‐19	4
Molecular testing of metastaticnon‐smallcell lung cancer in theAsia‐Pacificregion	4
Counting the cost of bronchiectasis	4
Abstracts	4
Pulmonary hypertension in Saudi Arabia: First data from the SAUDIPH registry with a focus on pulmonary arterial hypertension	4
Variability of fractional exhaled nitric oxide is associated with the risk and aetiology of COPD exacerbations	4
Racial and ethnic disparities in antifibrotic therapy in idiopathic pulmonary fibrosis	4
Ipsilateral and contralateral hemidiaphragm dynamics in symptomatic pleural effusion: The 2nd PLeural Effusion And Symptom Evaluation (PLEASE‐2) Study	4